144 (Dantrolene sodium 25 mg)
Pill imprint 144 has been identified as Dantrolene sodium 25 mg.
Dantrolene is used in the treatment of chronic spasticity; malignant hyperthermia and belongs to the drug class skeletal muscle relaxants. Risk cannot be ruled out during pregnancy. Dantrolene 25 mg is not a controlled substance under the Controlled Substance Act (CSA).
Dantrolene sodium
- Imprint:
- 144
- Strength:
- 25 mg
- Color:
- Orange / Tan
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Skeletal muscle relaxants
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- JHP Pharmaceuticals, LLC
More about dantrolene
Consumer resources
- Other brands: Dantrium, Dantrium Intravenous, Ryanodex, Revonto
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
